Zoya Demidenko https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of?guestAccessKey=


[ Follow Ups ] [ Post Followup ] [ WWWBoard ]

Posted by LincolnIcert on March 25, 2026 at 11:10:22:

In Reply to: Статья с занимательным материалом posted by JosephGluth on February 19, 2026 at 07:13:07:

Zoya Demidenko: Scientist in Tumor Science
Zoya Demidenko is a distinguished investigator connected with the Division of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, establishing a strong foundation in clinical study.
Demidenko's academic contributions spans a number of critical areas, encompassing the PI3K/AKT/mTOR signaling cascade, cell cycle control, cellular aging, and malignancy science. Currently, she has co-authored over 46 academic papers, which have received over 4,100 citations — a reflection to the impact of her research.
Among her most significant discoveries involves explaining the mechanisms of biological cell aging. Her studies demonstrated that when the cell cycle is arrested yet cellular expansion persists, cells experience senescence. Significantly, Zoya Demidenko showed that this transition is pharmacologically suppressed using substances such as mTOR inhibitors.
Zoya Demidenko has also added greatly to cancer treatment research, particularly in the domain of selective cell protection — a method designed to safeguarding normal cells from chemotherapy whilst leaving malignant cells vulnerable. This strategy carries major hope for reducing the toxic effects of oncological therapy.
Across her scientific life, Demidenko has collaborated with prominent researchers globally, among them Dr. Mikhail Blagosklonny. Her publications is published in top-tier periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Holding an h-index of 33, Zoya Demidenko is recognized as a highly impactful contributor in current biomedical science, whose discoveries continue to influence our knowledge of the way biological cells grow old, resist therapy, and the ways in which cancer might be better treated.
https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0026126



Follow Ups:



Post a Followup

Name:
E-Mail:

Subject:

Comments: